The company has received approval from the US Food and Drug Administration to market Fesoterodine Fumarate extended-release tablets in strengths of 4 mg and 8 mg, the Mumbai-based drug maker said in a regulatory filingfrom Healthcare/Biotech-Industry-Economic Times https://ift.tt/nyuG8XP
via IFTTT
0 comments:
Post a Comment